OCT 20, 2015 11:00 AM PDT

New Monkey Model Discovered For Studying Mother-to-Fetus Cytomegalovirus Infections

WRITTEN BY: Kara Marker
Cytomegalovirus (CMV) is the leading infectious cause of birth defects, and until now scientists had no effective way of developing a preventative vaccine.

According to the Centers for Disease Control and Prevention (CDC), pregnant women can transmit CMV through the placenta to their fetus when the mother is infected during pregnancy. Although birth defects only occur in some babies who receive a CMV infection from their mothers, at least a quarter of these infants will develop neurological impairment either at birth or later in infancy or childhood. One-third of pregnant women are exposed to CMV, and 5000 children per year are born with or develop birth defects due to a CMV infection. 
A Rhesus macaque and her baby
Although CMV is treatable, the treatment is not safe for pregnant women. Scientists have struggled to develop a vaccine without a proper mammal model. Scientists needed to know what kind of immune response was necessary to protect mothers and their babies from CMV, but until now, guinea pigs were the only mammals known to also transmit CMV from mother to fetus via the placenta. The dissimilarities between humans and guinea pigs were too large for them to be useful as models of disease. 

Fortunately, Duke Medicine discovered and published in Proceedings of the National Academy Of Sciences this week that Rhesus macaque monkey mothers also transmit CMV to their fetuses, and now they can be used as animal models for developing a CMV vaccine for pregnant women. Senior author Sallie R. Permar, M.D., Ph.D., of the Duke Human Vaccine Institute, is excited now that scientists can "manipulate each arm of the immune system" by studying these monkeys.  

The Duke scientists made this discovery through a series of three experiments.
  1. CD4 helper T cell population was depleted in monkeys bred free of CMV.  When pregnant mothers were infected with CMV, the virus passed through the placenta and caused miscarriages. 
  2. CMV-negative mothers were infected with CMV but their immune systems were not disrupted. Babies were infected with CMV from their mothers but were otherwise healthy (no miscarriages). 
  3. Control group of pregnant mothers with natural CMV infections and depleted CD4 helper T cells did not transmit CMV to their fetuses.
CMV Monkey Model"This told us not only that the virus could be transmitted through the placenta, but that the mother's immune system was playing an important role in the severity of the infection," Permar adds.

The next step for Duke Medicine is to determine what kind of vaccine would work best to defend monkeys (and humans) from passing CMV to their children. The scientists are considering neutralizing antibody vaccines and T cell vaccines. Only time will tell which option will successfully provide immunity from CMV. 

Watch the following video to hear from mothers affected by CMV.


Source: Science Daily and Duke University 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 02, 2020
Immunology
APR 02, 2020
Potential New COVID-19 Vaccine is Delivered by Patch
The coronavirus pandemic caused by SARS-CoV-2 is demanding the world's immediate attention.
APR 07, 2020
Microbiology
APR 07, 2020
Second COVID-19 Vaccine Enters Human Trials
Yesterday, Inovio Pharmaceuticals, Inc. announced that it will begin human trials on a potential vaccine for COVID-19.
APR 21, 2020
Immunology
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
MAY 02, 2020
Immunology
MAY 02, 2020
Cellular "Cleaning Crews" Get Busy During Spinal Cord Injury
  Nerve cells transmit and receive information traversing the human body in the form of electrical impulses. These ...
JUN 09, 2020
Immunology
JUN 09, 2020
Peacekeeping Engineered T Cells Restore the Balance in Diabetes
For patients with type 1 diabetes, hope is around the corner with a new experimental therapy that uses genetically modif ...
JUN 15, 2020
Drug Discovery & Development
JUN 15, 2020
New Antibiotic 'Irresistin' Defeats All Resistant Bacteria
Researchers from Princeton University have identified a compound capable of killing both Gram-positive and Gram-negative ...
Loading Comments...